TrialCancer2014

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Debra L Barton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.